Integration of machine learning and pharmacogenomic biomarkers for predicting response to antidepressant treatment: Can computational intelligence be used to augment clinical assessments?

Arjun P. Athreya, Ravishankar Iyer, Liewei Wang, Richard M. Weinshilboum, William V. Bobo

Research output: Contribution to journalReview article

Original languageEnglish (US)
Pages (from-to)983-988
Number of pages6
JournalPharmacogenomics
Volume20
Issue number14
DOIs
StatePublished - Jan 1 2019

Keywords

  • antidepressants
  • artificial intelligence
  • clinical response
  • depression
  • major depression

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Pharmacology

Cite this